News & Trends

• 302025-09

  Breaking News: Salubris Achieves Phase Progress in Two Independently Innovated Biologic Drugs

• 292025-09

  Latest! Salubris' SAL0140 New Indication Clinical Trial Application Accepted, Potential Breakthrough in Hypertension Treatment

• 192025-09

  Salubris' Class 1 Biological Drug Ticalicibart Injection Marketing Application Accepted

• 052025-09

  Great News! Enaroy® Gains New Indication Approval for Treating Anemia in Dialysis Patients with Chronic Kidney Disease

• 052025-09

  Salubris' Small Molecule Drug SAL0139 Clinical Trial Application Accepted for Hyperlipidemia Treatment

• 172025-07

  Breaking News! Base Editing Therapy YOLT-101 Clinical Trial Approved for Familial Hypercholesterolemia